Featured
Landmark Phase II Trial Reveals Novel CAR-T Therapy Achieves Unprecedented Tumor Shrinkage in Aggressive Pancreatic Cancer
A landmark Phase II clinical trial published on July 7, 2026, reveals that a novel dual-targeting CAR-T cell therapy, PB-701, has achieved unprecedent...
Read Full Story →